Biopharmaceutical products are facing a prosperous future. The 2016 ISPE Europe Conference on Biotechnology, Reinventing Commercial Bio Manufacturing, collects novel tools in knowledge management, process science, and technological advancements to tackle these future challenges, which include:
Increased competition by additional approvals of biosimilars
Enhanced regulatory requirements for traceability along the process development life cycle
Urgency for new technologies
Solutions for process optimisation
Transparency in process development
We are proud to have assembled an innovative programme of highly respected speakers from regulatory, manufacturers, service providers, and academia to present best practices and case studies.
Why attend?
Learn about GMP challenges and opportunities for biomanufacturing
Understand the implications of the new regulations, like Annex 1 and 2, for biopharmaceuticals
Discuss and explore success factors of knowledge management and technology transfer in Biopharma
See first-hand innovative solutions in process development
Four Plant Visits options available in Industriepark Höchst at Sanofi:
Multi-Insulin Plant
Lantus (Insulin) Plant
Cell Culture Pilot Plant for Development
Höchst Industry Park Tour (History and Current Operation)
Increased competition by additional approvals of biosimilars
Enhanced regulatory requirements for traceability along the process development life cycle
Urgency for new technologies
Solutions for process optimisation
Transparency in process development
We are proud to have assembled an innovative programme of highly respected speakers from regulatory, manufacturers, service providers, and academia to present best practices and case studies.
Why attend?
Learn about GMP challenges and opportunities for biomanufacturing
Understand the implications of the new regulations, like Annex 1 and 2, for biopharmaceuticals
Discuss and explore success factors of knowledge management and technology transfer in Biopharma
See first-hand innovative solutions in process development
Four Plant Visits options available in Industriepark Höchst at Sanofi:
Multi-Insulin Plant
Lantus (Insulin) Plant
Cell Culture Pilot Plant for Development
Höchst Industry Park Tour (History and Current Operation)
